China Universal Asset Management Company’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-195
| Closed | -$3.93K | – | 460 |
|
|
2023
Q3 | $3.93K | Buy |
195
+95
| +95% | +$1.91K | ﹤0.01% | 404 |
|
|
2023
Q2 | $2.67K | Sell |
100
-2
| -2% | -$53 | ﹤0.01% | 412 |
|
|
2023
Q1 | $5.98K | Buy |
102
+47
| +85% | +$2.75K | ﹤0.01% | 346 |
|
|
2022
Q4 | $2.81K | Buy |
55
+5
| +10% | +$255 | ﹤0.01% | 349 |
|
|
2022
Q3 | $4K | Buy |
+50
| New | +$4K | ﹤0.01% | 303 |
|